These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 9847926)

  • 61. Adverse events with medical devices in anesthesia and intensive care unit patients recorded in the French safety database in 2005-2006.
    Beydon L; Ledenmat PY; Soltner C; Lebreton F; Hardin V; Benhamou D; Clergue F; Laguenie G
    Anesthesiology; 2010 Feb; 112(2):364-72. PubMed ID: 20098139
    [TBL] [Abstract][Full Text] [Related]  

  • 62. FDA approves silicone breast implants 14 years after their withdrawal.
    Tanne JH
    BMJ; 2006 Dec; 333(7579):1139. PubMed ID: 17138981
    [No Abstract]   [Full Text] [Related]  

  • 63. Europe is updating rules on medical devices after implant fiasco.
    Watson R
    BMJ; 2012 Jan; 344():e766. PubMed ID: 22290299
    [No Abstract]   [Full Text] [Related]  

  • 64. Are silicone gel breast implants safe?
    Solomon G
    Cancer Invest; 2000; 18(3):281-4. PubMed ID: 10754996
    [No Abstract]   [Full Text] [Related]  

  • 65. Dismissing the evidence: the medical response to women with silicone implant-related disorders.
    Dumble LJ
    Health Care Women Int; 1996; 17(6):515-25. PubMed ID: 9119771
    [No Abstract]   [Full Text] [Related]  

  • 66. Breast implants. A review.
    Van Zele D; Heymans O
    Acta Chir Belg; 2004 Apr; 104(2):158-65. PubMed ID: 15154572
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Silicone gel breast implant failure and frequency of additional surgeries: analysis of 35 studies reporting examination of more than 8,000 explants.
    Marotta JS; Widenhouse CW; Habal MB; Goldberg EP
    J Biomed Mater Res; 1999; 48(3):354-64. PubMed ID: 10398041
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Physician knowledge, attitudes, and behavior related to reporting adverse drug events.
    Rogers AS; Israel E; Smith CR; Levine D; McBean AM; Valente C; Faich G
    Arch Intern Med; 1988 Jul; 148(7):1596-600. PubMed ID: 3382304
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Detecting software failures in the MAUDE database: a preliminary analysis.
    Pecoraro F; Luzi D
    Stud Health Technol Inform; 2013; 192():1098. PubMed ID: 23920872
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Autologous cultured chondrocytes: adverse events reported to the United States Food and Drug Administration.
    Wood JJ; Malek MA; Frassica FJ; Polder JA; Mohan AK; Bloom ET; Braun MM; Coté TR
    J Bone Joint Surg Am; 2006 Mar; 88(3):503-7. PubMed ID: 16510814
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Indoor tanning injuries: an evaluation of FDA adverse event reporting data.
    Dowdy JC; Sayre RM; Shepherd JG
    Photodermatol Photoimmunol Photomed; 2009 Aug; 25(4):216-20. PubMed ID: 19614901
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dental device-associated problems: an analysis of FDA postmarket surveillance data.
    Fuller J; Parmentier C
    J Am Dent Assoc; 2001 Nov; 132(11):1540-8. PubMed ID: 11806067
    [TBL] [Abstract][Full Text] [Related]  

  • 73. When silicone medical devices were under attack: A regulatory leviathan.
    Fisher JC
    Bull Am Coll Surg; 2015 Dec; 100(12):14-20. PubMed ID: 26749965
    [No Abstract]   [Full Text] [Related]  

  • 74. An analysis of FDA passive surveillance reports of seizures associated with consumption of aspartame.
    Tollefson L; Barnard RJ
    J Am Diet Assoc; 1992 May; 92(5):598-601. PubMed ID: 1573143
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The PIP crisis: déjà vu all over again?
    Freshwater MF
    J Plast Reconstr Aesthet Surg; 2012 Jun; 65(6):840-3. PubMed ID: 22564746
    [No Abstract]   [Full Text] [Related]  

  • 76. "Junk science" in the courtroom. Causes and effects.
    Price JM; Gates GS
    ASAIO J; 1995; 41(2):139-42. PubMed ID: 7640415
    [No Abstract]   [Full Text] [Related]  

  • 77. Major Clinical Adverse Events of Breast Implant in the Manufacturer and User Facility Device Experience Database.
    Su B; Chen L; Zhang B; Wang H; Zhou J; Du B
    J Patient Saf; 2024 Jun; 20(4):267-271. PubMed ID: 38635526
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Consequences of the U.S. Food and Drug Administration-Directed Moratorium on Silicone Gel Breast Implants: 1992 to 2006.
    Cole NM
    Plast Reconstr Surg; 2018 May; 141(5):1137-1141. PubMed ID: 29697610
    [TBL] [Abstract][Full Text] [Related]  

  • 79. On the safety of silicone gel breast implants.
    Puckett CL
    Cancer Invest; 2000; 18(3):278-80. PubMed ID: 10754995
    [No Abstract]   [Full Text] [Related]  

  • 80. An analysis of telephone interview data collected in 1992 from 820 women who reported problems with their breast implants to the food and drug administration.
    Coon SK; Burris R; Coleman EA; Lemon SJ
    Plast Reconstr Surg; 2002 May; 109(6):2043-51. PubMed ID: 11994612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.